CLINICAL TRIAL

Treatment for Mucositis

Waitlist Available · < 65 · All Sexes · Milwaukee, WI

This study is evaluating whether LED therapy can prevent mucositis in children who are receiving chemotherapy.

See full description

About the trial for Mucositis

Eligible Conditions
Neoplasms, Plasma Cell · Myelodysplastic Syndromes · Myeloproliferative Disorders · Pain · Syndrome · Oral Complications · Sarcoma · Leukemia · Myelodysplastic-Myeloproliferative Diseases · Neuroblastoma · Plasmacytoma · Mucositis · Chronic Myeloproliferative Disorders · Renal Cancers · Multiple Myeloma · Ovarian Cancer · Multiple Myeloma and Plasma Cell Neoplasm · Lymphoma · Myelodysplastic/Myeloproliferative Neoplasms · Neoplasms · Preleukemia

Treatment Groups

This trial involves a single treatment. Treatment is the primary treatment being studied. Participants will all receive the same treatment. There is no placebo group. The treatments being tested are in Phase 2 and have already been tested with other people.

Main TreatmentA portion of participants receive this new treatment to see if it outperforms the control.
Control TreatmentAnother portion of participants receive the standard treatment to act as a baseline.

Eligibility

This trial is for patients born any sex aged 65 and younger. There are 10 eligibility criteria to participate in this trial as listed below.

Inclusion & Exclusion Checklist
Mark “yes” if the following statements are true for you:
Fertile patients must use contraception to prevent pregnancy. show original
(BMT) had a significantly increased risk of death in the first 100 days after transplantation show original
2 to 18
I am not pregnant. show original
The woman's pregnancy test came back negative. show original
There is no photophobia. show original
The text is saying that the person must have emotional, cognitive, and mental maturity to tolerate a light-emitting diode therapy application and oral examination without getting mad. show original
The following text is about the characteristics of a disease show original
The text does not specify anything. show original
No pulmonary dysfunction that would increase significantly the risk of requiring intubation during the first 21 days after transplantation
View All
Odds of Eligibility
Unknown<50%
Be sure to apply to 2-3 other trials, as you have a low likelihood of qualifying for this one.Apply To This Trial
Similar Trials

Approximate Timelines

Please note that timelines for treatment and screening will vary by patient
Screening: ~3 weeks
Treatment: varies
Reporting: Up to 5 years
Screening: ~3 weeks
Treatment: Varies
Reporting: Up to 5 years
This trial has approximate timelines as follows: 3 weeks for initial screening, variable treatment timelines, and reporting: Up to 5 years.
View detailed reporting requirements
Trial Expert
Connect with the researchersHop on a 15 minute call & ask questions about:
- What options you have available- The pros & cons of this trial
- Whether you're likely to qualify- What the enrollment process looks like

Measurement Requirements

This trial is evaluating whether Treatment will improve 3 primary outcomes and 1 secondary outcome in patients with Mucositis. Measurement will happen over the course of .

Mean change in oral mucositis index (OMI) score from baseline to maximum score within 14 days posttransplant
Mean change in pain score from baseline to maximum score within 14 days posttransplant
Proportion of patients not experiencing ulcerative mucositis within the first 14 days posttransplant
Time to heal

Patient Q & A Section

Ask a question about the study

Other questions from users

Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any geographic restrictions to consider when applying for this trial?

Patients from any state can participate in this trial, so long as they are able to attend all treatment sessions.

Will my insurance cover participating in this trial?

In order to understand how insurance coverage works for this trial, you will need to contact the study coordinator.

See if you qualify for this trial
Get access to this novel treatment for Mucositis by sharing your contact details with the study coordinator.